Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) saw a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 193,300 shares, a growth of 48.2% from the February 13th total of 130,400 shares. Based on an average daily trading volume, of 218,900 shares, the days-to-cover ratio is presently 0.9 days. Currently, 36.2% of the shares of the stock are short sold.
Bone Biologics Stock Performance
NASDAQ:BBLG opened at $0.83 on Friday. Bone Biologics has a 1-year low of $0.71 and a 1-year high of $4.25. The business has a 50 day moving average of $0.99 and a 200 day moving average of $1.27.
About Bone Biologics
See Also
- Five stocks we like better than Bone Biologics
- How to start investing in penny stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The Basics of Support and Resistance
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Quiet Period Expirations Explained
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.